Edward Hu - 01 Jan 2023 Form 3 Insider Report for Ambrx Biopharma Inc.

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Edward Hu
Issuer symbol
N/A
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
3
Filing time
03 Jan 2023, 17:24:18 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMAM Ordinary Shares 1,215,472 01 Jan 2023 By 2019 Hu Family Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
F2 These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person is the grantor of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.